Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-posit... von Hurvitz, Sara A, Bosserman, Linda D, Chan, David, Hagenstad, Christopher T, Kass, Frederick C, Smith, Frederick P, Rodriguez, Gladys I, Childs, Barrett H, Slamon, Dennis J

Volltext

Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature von Hagenstad, Christopher T, Kilpatrick, Scott E, Pettenati, Mark J, Savage, Paul D

Volltext

Updated Results on the Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of the B-Cell Receptor Sig... von Sharman, Jeffrey P., Shustov, Andrei R., Smith, Mitchell R., Hagenstad, Christopher T., Kolibaba, Kathryn S., Abella-Dominicis, Esteban, Zhang, Danjie, Mitra, Siddhartha, Yasenchak, Christopher A., Awan, Farrukh T.

Volltext

Inflammatory Myofibroblastic Tumor With Bone Marrow Involvement von Hagenstad, Christopher T., Kilpatrick, Scott E., Pettenati, Mark J., Savage, Paul D.

Volltext

A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer von HECHT, J. Randolph, MITCHELL, Edith, DEETER, Robert, SHAHIN, Seta, AMADO, Rafael G, CHIDIAC, Tarek, SCROGGIN, Carroll, HAGENSTAD, Christopher, SPIGEL, David, MARSHALL, John, COHN, Allen, MCCOLLUM, David, STELLA, Philip

Volltext

Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer von BENDELL, Johanna C, NEMUNAITIS, John, VUKELJA, Sasha J, HAGENSTAD, Christopher, CAMPOS, Luis T, HERMANN, Robert C, SPORTELLI, Peter, GARDNER, Lesa, RICHARDS, Donald A

Volltext

Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of B-Cell Receptor Pathway Signaling von Sharman, Jeff P., Shustov, Andrei R., Smith, Mitchell R., Boyd, Thomas E., Hagenstad, Christopher, Kolibaba, Kathryn S., Abella, Steve, He, Jing, Eng, Clarence, Hu, Jing, Reddy, Anita, Mitra, Siddhartha, Yasenchak, Christopher A., Awan, Farrukh T.

Volltext

A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01) von Hurvitz, Sara A, Allen, Heather J, Moroose, Rebecca L, Chan, David, Hagenstad, Christopher, Applebaum, Steven H, Patel, Giribala, Hu, Eddie H, Ryba, Nancy, Lin, Lii-Shin, Wang, HeJing, Glaspy, John, Slamon, Dennis J, Kabbinavar, Fairooz

Volltext